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 Implication for health policy/practice/research/medical edu-
cation:
Access to suﬃcient safe blood and blood products is a basic medical 
“right” for all patients in need of such products. Therefore, policy 
makers should implement a balanced national blood policy that 
compromises neither the safety nor the availability of the blood. 
  c 2011, BRCGL, Published by Kowsar M.P.Co.  All rights reserved.
Blood transfusion at present and for the foreseeable 
future will be an essential component of health care sys-
tems. Blood transfusion is one of the most important life-
saving medical interventions which save millions of lives 
each year. Constant needs of patients waiting for surgery 
or suﬀering from trauma, severe anemia or complica-
tions of pregnancy to the blood and/or its components 
which necessitates the availability of timely and safe 
blood transfusion in healthcare facilities (1). Despite the 
presence of substantial concerns regarding the safety of 
blood transfusion practices in some countries (2), recent 
achievements in the ﬁeld of transfusion safety have pro-
vided fruitful results. The world’s blood supply has never 
been as safe as it is today. During the past several decades 
dramatic progress has been made in reducing the risk of 
transfusion transmitted infections (TTI). In some coun-
tries this risk has been reduced to a negligible level (3). 
These achievements can mainly be credited to improve-
ments in policy and structure, recruitment of volunteer 
donors, the implementation of basic concepts of qual-
ity assurance in blood services and the use of high level 
technology in blood transfusion practices. In addition to 
these universal interventions some countries have also 
implemented interventions speciﬁc to their own nation-
al health systems. 
Following US Food and Drug Administration (FDA) rec-
ommendations in the 1980s, some blood establishments 
inside the US and in a number of other countries have im-
plemented the Conﬁdential Unit Exclusion (CUE) method 
as a way to improve blood safety in their establishments. 
In this intervention donors may conﬁdentially request 
that the blood service discards their donated blood af-
ter it has been donated, due to possible safety risks to 
the recipients from their blood donation. Although FDA 
recommendations for the implementation of CUE in the 
1980s as a method to improve blood safety could be justi-
ﬁed on the grounds of absence of reliable laboratory test-
ing for HIV at that time, it withdrew its recommendation 
at a later stage. Therefore, due to the unproven eﬃcacy 
of this intervention in improving blood safety, enthusi-
asm regarding the CUE method faded before its universal 
implementation and many authors seriously questioned 
its eﬃcacy in improving blood safety. These reports have 
weighed the beneﬁts of CUE against its main disadvan-
tage, which is the discarding of a considerable number 
of donated blood units(4). Investigators mentioned that 
despite the minimal eﬀect of the CUE method in improv-
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amount of unnecessary wastage of donated blood units. 
This phenomenon is more pronounced in developing 
countries where low educated donors make up the larg-
est proportion of the donors’ pool. Ironically in these 
countries a shortage of blood is also more prevalent and 
providing suﬃcient blood is a challenging task. In some 
developed countries which have implemented the CUE 
option, the donor usage rate of CUE averages 0.5% or less, 
while this ﬁgure in developing countries is about 1%. This 
might indicate that the use of CUE in these countries is 
somehow tied to misunderstandings by donors regard-
ing CUE’s purpose and implications. A unit of blood is 
a scarce and precious lifesaving gift from donors and 
should be regarded accordingly by blood services. There-
fore donated blood should only be discarded on the basis 
of a conﬁrmed or at least justiﬁed presence of risk to the 
donors. Although there is a general consensus that vol-
unteer donors will provide the safest blood donations, in 
countries which lack suﬃcient volunteer donors, recruit-
ment of replacement donors is considered to be a practi-
cal approach for providing suﬃcient blood (5).
Iran is among the countries which has very reliable na-
tional blood transfusion services (2). CUE has been imple-
mented in Iran’s blood-transfusion system since 2003. 
However, recently the eﬀectiveness of the CUE method in 
Iran’s national blood transfusion service has been inves-
tigated. Results of these investigations and subsequent 
debates have been published in “Hepatitis Monthly” (4, 
6, 7). In one of these papers the authors reported a sig-
niﬁcantly higher risk of HBV and HCV markers in donors 
who used the CUE option. Therefore, the authors con-
cluded that CUE is an eﬀective option for identifying do-
nors with an increased risk of HBV and HCV infection (6). 
However, even in the data presented in this paper over 
94% of HBsAg positive donations came from donors who 
did not use the CUE option to exclude their donation 
from being used. This paper has not reported the sensi-
tivity and Positive Predictive Value (PPV) for the present-
ed data. Therefore, based on this study alone it is very dif-
ﬁcult to measure the impact of CUE on blood safety.
However, most of the other international studies have 
reported only low, albeit variable, sensitivity and PPV for 
the CUE method. Variability could be attributed to diﬀer-
ent methods of CUE application and the educational sta-
tus of the blood donors. The CUE method is very much 
dependent on its application procedure. It has been re-
ported that a small change in application methods of 
the CUE has drastically modiﬁed the frequency that CUE 
is used by blood donors. One study reported that modi-
fying the procedure for donors’ use of CUE and, more 
importantly, providing clear and self-explanatory CUE 
forms had a signiﬁcant eﬀect on the CUE usage rate. Such 
modiﬁcations have reduced the use of CUE in Germany 
by more than 30% (8). In a recent published paper Farhadi 
et al. evaluated the eﬃcacy of CUE in a Tehran blood cen-
ter (7). They concluded that the CUE option had low sen-
sitivity and PPV. It had minimal eﬀectiveness in reducing 
transmissible infectious diseases through window peri-
od units. In this study ﬁrst time donors and donors who 
had a low level of education used the CUE option more 
often compared to repeat donors. This might indicate 
that these groups of donors are not suﬃciently aware 
of CUE and its implications. However, they did not ﬁnd 
a signiﬁcant diﬀerence for positive test results for viral 
markers between CUE and non-CUE user donors. In this 
study more than 97% of donations with conﬁrmed HBSAg 
positive test results were from non-CUE user donors. The 
fact that the majority of positive donated bloods for TTI 
came from non-CUE user donors emphasizes the impor-
tance of suitable donor screening methods instead of re-
lying on the use of CUE by high-risk donors.
Although there is no robust evidence for improving the 
safety of blood transfusions as a result of CUE implemen-
tation in Iran, the universal application of CUE in all Ira-
nian blood services has caused the unnecessary wastage 
of tens of thousands of donated blood units. In practi-
cal terms CUE should be designed carefully in order to 
exclude blood samples from high-risk donors who seek 
safety tests through transfusion services. These clearly 
indicate that the use of better donor screening and se-
lection methods compared with the use of CUE, might 
be more eﬃcient in excluding high risks donors from 
donating blood and prevent the unnecessary wastage of 
blood donations. Since the reported data shows that the 
CUE method is not as eﬃcient as it was intended to be, 
especially in countries with a high rate of CUE use, such 
as Iran, it is important that both the procedures and 
donors’ motivations for use of the CUE are investigated 
thoroughly. 
In conclusion, although the CUE may modestly en-
hance blood safety in some blood transfusion services, 
this occurs at the cost of discarding a substantial num-
ber of blood units. Therefore, the CUE option should be 
re-evaluated in the broader national spectrum of blood 
transfusion services. Providing suﬃcient blood is of as 
much importance as the safety of the blood especially 
for those patients who are in urgent need of blood for 
life saving medical interventions. Patient’s access to suf-
ﬁcient blood is a basic medical “right”. Therefore policy 
makers should implement a balanced national blood 
policy that neither compromises the safety nor the avail-
ability of the blood and blood components.
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